CD44 and neoplasm: By sorting a subpopulation of CD44+/CD24-(low) cells from human breast cancer tissue, Al-Hajj et al. were the first to demonstrate that these cells can be enriched for breast CSCs and to develop a tumor in immune-deficient mice [18].